News – Page 900 – Endpoints News

Worthless? Short attack on FibroGen claims their anemia drug roxa has a lethal Achilles’ heel — and it’s going ...

6 years ago

Right on deadline, Trump taps Stephen Hahn as new FDA commish. Now what?

6 years ago

Gilead's ex-investor relations chief takes CFO job at Sangamo; Former GE Healthcare exec takes the helm at Vectura ...

6 years ago

Novo dumps proposed Rybelsus successor for newer model

6 years ago

Data suggest gene, cell therapy trial initiations in Europe lag behind North America — here's why

6 years ago

Eight years after a landmark buyout, Sanofi agrees to pay aggrieved Genzyme shareholders $315M to settle ...

6 years ago

Paratek's top antibiotic fails to clear a key competitive hurdle in head-to-head studies

6 years ago

Novartis' Cosentyx misses main goal in head-to-head trial with AbbVie's Humira

6 years ago

Novartis admits to ‘mistake’ after partial clinical hold placed on Zolgensma trial

6 years ago

Amgen takes a $2.7B stake in BeiGene, gaining a prominent ally in China to help seize a leading role in cancer drug ...

6 years ago

Vik Bajaj unveils Foresite's new incubator, looking to hatch future giants crossing tech and healthcare

6 years ago

SinoMab BioScience, Alphamab Oncology make their way to the Hong Kong Stock Exchange

6 years ago

AbbVie showcases positive PhIII data for Rinvoq; RAPT prices on low end for IPO

6 years ago

FDA to require certain IND safety reports be submitted to FAERS

6 years ago

Thermo Fisher hooks gut onto its gene therapy pipeline, inks new collaboration pact

6 years ago

Sanofi's oncology R&D group marks a pair of setbacks on isatuximab/Libtayo combo as cancer studies fizzle out

6 years ago

Astellas rejoins the autoimmune antibody craze with Pandion partnership

6 years ago

Oz Azam beefs up Tmunity's total raise to $231M as they steer toward human data in the drive to cell therapy 2.0

6 years ago

Merck's last crack at salvaging a $2.5B jury verdict in hep C patent showdown is shot down by appeals court

6 years ago

Roche signs up Dicerna in a $200M-plus cash alliance to help develop a hep B cocktail, capping the biotech's big year

6 years ago

Neuroscience biotech led by former Pfizer crew wins $17M to target toxic tau

6 years ago

Vivek Ramaswamy trades top execs and adds stealthy vant to $3B sale, while his new partner tosses Myovant $350M

6 years ago

UK's Johnson, Corbyn bicker over US trade and Vertex deal

6 years ago

A RIP1 contender fails to make the cut at GSK after a fast fizzle in pancreatic cancer

6 years ago

First page Previous page 897 898 899900901 902 903 Next page Last page